Sign in
4

Changes in Ownership

Kiniksa Pharmaceuticals International, plc Filed Acc 0001415889-22-003991

Options or other derivatives

  • CHIEF ACCOUNTING OFFICER acquired 47,190 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Megna Michael R CHIEF ACCOUNTING OFFICER 2022-04-07 Grant or award · Share Option +31,460 31,460 D
Megna Michael R CHIEF ACCOUNTING OFFICER 2022-04-07 Grant or award · Restricted Share Unit +15,730 15,730 D
Loading xslF345X03/form4-04112022_040411.xml…